课题基金 / 基金详情

MECHANISMS FOR PITUITARY TUMORIGENESIS

MECHANISMS FOR PITUITARY TUMORIGENESIS
垂体肿瘤发生机制
批准号:
6624736
负责人:
SHLOMO MELMED
金额:
$25.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-15 至 2003-11-30

项目摘要

项目成果

SHLOMO MELMED的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pituitary adenomas are common benign neoplasms giving rise to disorders of growth, reproductive function, cortisol production and local central pressure effects. Although recently determined to be monoclonal, the genetic mechanisms involved in pituitary cell transformation are unclear. This proposal will characterize the transforming properties of PTTG, a novel pituitary tumor derived protein. We used differential RNA display to identify a rat pituitary derived transforming gene (PTTG) which encodes a 199 a.a. novel protein. Now, we will isolate and study human PTTG and assign its chromosomal locus. PTTG expression will be tested in hormone- secreting (PRL, GH, ACTH) and non-functional pituitary tumors, and its abundance assessed as a function of pituitary adenoma grading, invasinenes, hormonal activity and ultimately long-term clinical outcome. Cellular localization of PTTG will also be determined in these tumors by double immunostaining and in situ techniques. Models of pituitary enlargement (pregnancy and estrogen-induced prolactinomas) will be used to determine PTTG expression in the pathogenesis of the pituicyte to hyperplasia to adenoma formation. PTTG in vitro and in vivo transforming properties will be determined in double agar transformation assays, nude mouse tumorigenesis and growth factor regulation will be assessed. Effects of inducible PTTG expression on cell proliferation will also be assessed. These studies will thus provide mechanistic insight into the pathogenesis of prolactinomas, acromegaly, Cushing's Disease and non-secreting pituitary tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
  • 批准号:
    10003845
  • 项目类别:
  • 资助金额:
    $46.78万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Mechanisms for GH action on epithelial cells
  • 批准号:
    10578571
  • 项目类别:
  • 资助金额:
    $36.74万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Mechanisms for GH action on epithelial cells
  • 批准号:
    9893867
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
  • 批准号:
    8773516
  • 项目类别:
  • 资助金额:
    $23.44万
  • 财政年份:
    2014
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
海外基金